Treatment Planning Systems and Advanced Image Processing Market Trends

• Market participants are increasingly adopting artificial intelligence and machine learning to develop oncology software solutions, thereby enhancing treatment plans, diagnoses, and overall cancer management.
  
• Additionally, various initiatives and projects are being undertaken to create health information learning platforms aimed at improving the quality of oncology care. These efforts are anticipated to further drive market growth.
  
• For instance, in December 2023, ConcertAI announced the acquisition of CancerLinQ, an innovative oncology learning health system that had previously been a subsidiary of the American Society of Clinical Oncology (ASCO). In conjunction with this acquisition, ASCO entered into a multi-year collaboration agreement with CancerLinQ. This new partnership aimed to enhance and expand the utilization of real-world data, analytics, next-generation artificial intelligence, and other technologies to improve cancer care and expedite clinical research.